NCT03012061 Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma Status COMPLETED Phase PHASE2
NCT03005067 To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold Status COMPLETED Phase PHASE2
NCT03005041 Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects Status COMPLETED Phase NA
NCT03004846 A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT03004807 Role of Centrum® Silver® in Improving Micronutrient Status in Older Men Status COMPLETED Phase NA
NCT03001440 A 7-year Assessment on Subject Understanding of ZYBAN/ WELLBUTRIN Associated Risks Status COMPLETED Phase N/A
NCT02999100 Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women Status TERMINATED Phase PHASE1
NCT02992743 Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma Status COMPLETED Phase PHASE2
NCT02991872 A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children Status COMPLETED Phase PHASE4
NCT02991859 Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects Status COMPLETED Phase PHASE2
NCT02989727 Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine Status COMPLETED Phase PHASE4
NCT02987465 Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease. Status COMPLETED Phase N/A
NCT02986854 Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination Status COMPLETED Phase PHASE3
NCT02985450 A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada Status COMPLETED Phase N/A
NCT02982187 A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE4
NCT02981602 Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection Status COMPLETED Phase PHASE2
NCT02979639 Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age Status COMPLETED Phase PHASE3